首页|真性红细胞增多症中医治疗进展

真性红细胞增多症中医治疗进展

扫码查看
真性红细胞增多症是一种造血干细胞的克隆性骨髓增殖性疾病,该病合并症多,主要为血栓性疾病,会严重影响患者的生活质量.长期服用西药虽然能控制细胞数目的增长,但副作用较大,患者耐受性和依从性差.真性红细胞增多症生存期较长,中医治疗能明显改善患者症状、减少西药用量、减轻不良反应,中西医结合治疗更能提高患者的生活质量.综述近年来对真性红细胞增多症的病因及辩证论治方面的认识,展望未来中西医结合治疗的研究方向.
Progress in Traditional Chinese Medicine Treatment of Polycythemia vera
Polycythemia vera is a clonal myeloproliferative disease of hematopoietic stem cells,with many complications,mainly thrombotic diseases,which seriously affect the quality of life of patients.Although long-term use of Western medicine can control the growth of the number of cells,it has many side effects,and the patient's tolerance and compliance are poor.The survival period of this disease is longer,traditional Chinese medicine treatment can significantly improve the symptoms of patients,while reducing the amount of Western medicine,so as to reduce the adverse drug reactions.The integrated treatment of traditional Chinese and Western medicine can improve the quality of life of patients with this disease.This article reviews the research and understanding on the etiology,pathogenesis and dialectical treatment of Polycythemia vera in recent years,and looks forward to the future research direction of integrated treatment of traditional Chinese and Western medicine.

Polycythemia veratraditional chinese medicinereview

刘倩、张伟锋、张天译

展开 >

天津中医药大学第一附属医院血液科 天津 300381

天津中医药大学第二附属医院急诊科 天津 300150

真性红细胞增多症 中医 综述

国家自然科学基金

81803918

2024

天津科技
天津科学技术信息研究所

天津科技

影响因子:0.253
ISSN:1006-8945
年,卷(期):2024.51(9)